Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on BIT. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover the improved process for DPP-IV inhibitors reducing costs and enhancing yield. Ideal for reliable pharmaceutical intermediate supply chains and mass production.
Novel zinc-promoted asymmetric allylation for DPPIV inhibitors. High stereoselectivity, scalable route for API intermediates.
Patent CN111320535B reveals a low-cost route for 3-(benzyloxy)-1-cyclobutanone using Hunsdiecker reaction, offering significant supply chain advantages for API manufacturing.
Novel azabicyclic derivatives targeting EGFR T790M mutations offer high selectivity and reduced toxicity, enabling cost-effective API manufacturing and reliable supply chain solutions for oncology drugs.
Novel low-temperature synthesis of CAIX inhibitors significantly improves yield and purity, offering a reliable pharmaceutical intermediate supplier solution for advanced PET imaging probe manufacturing.
Novel chromone derivatives for diabetes treatment offering improved efficacy and simplified synthesis for reliable pharmaceutical intermediate supply chains.
Patent CN108623564B reveals a high-yield vanadium-catalyzed route for Dextro-Rabeprazole. Discover cost-effective manufacturing and superior enantioselectivity for your supply chain.
Patent CN109988161A details a telescoped synthesis for Empagliflozin, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Novel nickel-catalyzed route for JAK inhibitor intermediate reduces cost and avoids palladium. Ideal for reliable pharmaceutical intermediate supply chains.
Novel Pummerer reaction method for sulfur-containing aryl carbon glycosides. Mild conditions, high yield, suitable for API intermediate manufacturing.
Novel Suzuki coupling method for thienopyrimidine compounds. Enhances yield and scalability for pharmaceutical intermediate manufacturing supply chains.
Novel Suzuki coupling process for thienopyrimidine compounds enhances yield and scalability. Reduces waste and cost for pharmaceutical intermediates manufacturing supply chains.
Novel one-pot synthesis for neuraminidase inhibitors using acetic acid catalyst. Enhances yield and purity for pharmaceutical supply chains.
Patent CN119707980B details novel SMDC synthesis. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN101155801A details a Pd-catalyzed borylation route for high-purity indole intermediates, offering significant cost reduction in pharmaceutical manufacturing and scalable supply chain solutions.
Patent CN112359079B reveals a novel enzymatic route for Imatamine. Achieve high purity and cost reduction in API manufacturing with our scalable green chemistry solutions.
Novel triazole IDO inhibitor synthesis patent CN109748911A offers improved yield and purity for pharmaceutical intermediate manufacturing supply chains globally.
Patent CN113801010A reveals a high-yield route for 5-bromo-2-chlorobenzoic acid, a key SGLT2 inhibitor intermediate, offering superior purity and supply chain stability.
Patent CN103073508A details efficient synthesis of kinase inhibitors. Discover cost-effective routes for high-purity pharmaceutical intermediates targeting B-cell diseases.
Novel process for pyrido-benzazepine intermediates via glutaraldehyde cyclization. Enhances purity and scalability for ACE inhibitor production.